FDA Approves Onglyza (saxagliptin) for Type 2 Diabetes
FDA Approves Onglyza (saxagliptin) for Type 2 Diabetes
July 31, 2009
ROCKVILLE, Md., July 31, 2009--The U.S. Food and Drug Administration
today approved Onglyza (saxagliptin), a once-daily tablet to treat
Type 2 diabetes in adults. The medication is intended to be used with
diet and exercise to control high blood sugar levels.
July 31, 2009
ROCKVILLE, Md., July 31, 2009--The U.S. Food and Drug Administration
today approved Onglyza (saxagliptin), a once-daily tablet to treat
Type 2 diabetes in adults. The medication is intended to be used with
diet and exercise to control high blood sugar levels.
Comentarios
Publicar un comentario